<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="publisher-id">JOACP</journal-id><journal-title-group><journal-title>Journal of Anaesthesiology, Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0970-9185</issn><issn pub-type="epub">2231-2730</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23225932</article-id><article-id pub-id-type="pmc">3511949</article-id><article-id pub-id-type="publisher-id">JOACP-28-496</article-id><article-id pub-id-type="doi">10.4103/0970-9185.101940</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of efficacy of intra-articular morphine and steroid in patients with knee osteoarthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Beyaz</surname><given-names>Serbülent Gökhan</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib></contrib-group><aff id="aff1">Department of Anesthesia and Pain Management Center, Sakarya University Medical School, Sakarya, Turkey</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Serbülent Gökhan Beyaz, Associate Professor, Department of Anesthesiology and Pain Management Center, Sakarya University Medical School, Korucuk Campus, Adapazarı, Sakarya, Republic of Turkey. E-mail: <email xlink:href="sgbeyaz@gmail.com">sgbeyaz@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2012</year></pub-date><volume>28</volume><issue>4</issue><fpage>496</fpage><lpage>500</lpage><permissions><copyright-statement>Copyright: © Journal of Anaesthesiology Clinical Pharmacology</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="2714" xml_f="2727" txt_i="11" txt_f="24">Introduction:</offsets></title><p><offsets xml_i="2738" xml_f="3035" txt_i="25" txt_f="322">Primary therapeutic aim in treatment of osteoarthritis of the knee is to relieve the pain of osteoarthritis. The aim of this study was to compare the efficacy of intra-articular triamcinolone with intra-articular morphine in pain relief due to osteoarthritis of the knee in the elderly population.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3066" xml_f="3088" txt_i="324" txt_f="346">Materials and Methods:</offsets></title><p><offsets xml_i="3099" xml_f="3647" txt_i="347" txt_f="895">Patients between 50 and 80 years of age were randomized into three groups. Group M received morphine plus bupivacaine intra-articularly, Group T received triamcinolone plus bupivacaine intra-articularly, and Group C received saline plus bupivacaine intra-articularly. Patients were evaluated before injection and in 2nd, 4th, 6th, and 12th weeks after injection. First-line supplementary analgesic was oral paracetamol 1500 mg/day. If analgesia was insufficient with paracetamol, oral dexketoprofen trometamol 50 mg/day was recommended to patients.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3678" xml_f="3686" txt_i="897" txt_f="905">Results:</offsets></title><p><offsets xml_i="3697" xml_f="4239" txt_i="906" txt_f="1448">After the intra-articular injection, there was statistically significant decrease in visual analog scale (VAS) scores in Groups M and T, when compared to Group C. The decrease of VAS scores seen at the first 2 weeks continued steadily up to the end of 12th week. There was a significant decrease in Groups M and T in the WOMAC scores, when compared to Group C. There was no significant difference in the WOMAC scores between morphine and steroid groups. Significantly less supplementary analgesics was used in the morphine and steroid groups.</offsets></p></sec><sec id="st4"><title><offsets xml_i="4270" xml_f="4281" txt_i="1450" txt_f="1461">Conclusion:</offsets></title><p><offsets xml_i="4292" xml_f="4531" txt_i="1462" txt_f="1701">Intra-articular morphine was as effective as intra-articular triamcinolone for analgesia in patients with osteoarthritis knee. Intra-articular morphine is possibly a better option than intra-articular steroid as it has lesser side effects.</offsets></p></sec></abstract><kwd-group><kwd>Injection</kwd><kwd>knee</kwd><kwd>morphine</kwd><kwd>osteoarthritis</kwd><kwd>triamcinolone</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title><offsets xml_i="4731" xml_f="4743" txt_i="1710" txt_f="1722">Introduction</offsets></title><p><offsets xml_i="4754" xml_f="4912" txt_i="1723" txt_f="1881">Osteoarthritis of the knee is one of the most frequent forms of arthritis, especially in the elderly population, and is a major cause of pain and disability.[</offsets><xref ref-type="bibr" rid="ref1"><offsets xml_i="4945" xml_f="4946" txt_i="1881" txt_f="1882">1</offsets></xref><xref ref-type="bibr" rid="ref2"><offsets xml_i="4986" xml_f="4987" txt_i="1882" txt_f="1883">2</offsets></xref><offsets xml_i="4994" xml_f="5243" txt_i="1883" txt_f="2132">] Underlying cause of the disease is degradation of cartilage and its presents clinically is pain, stiffness, limited mobility of the involved joint. Main symptom of osteoarthritis of the knee is pain; therefore, primary aim is to relieve the pain.[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="5276" xml_f="5277" txt_i="2132" txt_f="2133">3</offsets></xref><xref ref-type="bibr" rid="ref4"><offsets xml_i="5317" xml_f="5318" txt_i="2133" txt_f="2134">4</offsets></xref><offsets xml_i="5325" xml_f="5385" txt_i="2134" txt_f="2194">] Intra-articular opioids are used in addition to steroids.[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="5418" xml_f="5419" txt_i="2194" txt_f="2195">5</offsets></xref><offsets xml_i="5426" xml_f="5427" txt_i="2195" txt_f="2196">–</offsets><xref ref-type="bibr" rid="ref7"><offsets xml_i="5460" xml_f="5461" txt_i="2196" txt_f="2197">7</offsets></xref><offsets xml_i="5468" xml_f="5469" txt_i="2197" txt_f="2198">]</offsets></p><p><offsets xml_i="5476" xml_f="5575" txt_i="2199" txt_f="2298">Morphine and endogenous opioids (enkephalins, dynorphins, and β-endorphines) stimulate δ-, κ-, and </offsets><italic><offsets xml_i="5583" xml_f="5584" txt_i="2298" txt_f="2299">μ</offsets></italic><offsets xml_i="5593" xml_f="5806" txt_i="2299" txt_f="2512">-opioid receptors. or/and βeta-endorphines) stimulate sigma, kappa-, and μ-opioid receptors. Activation of all three main receptors has biological effects, which are mediated primarily via central nervous system.[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="5839" xml_f="5840" txt_i="2512" txt_f="2513">8</offsets></xref><xref ref-type="bibr" rid="ref9"><offsets xml_i="5880" xml_f="5881" txt_i="2513" txt_f="2514">9</offsets></xref><offsets xml_i="5888" xml_f="6074" txt_i="2514" txt_f="2700">] After discovery of opioid receptors in peripheral nerve terminals, opioids were administered locally. Antinociceptive and anti-inflammatory effects of morphine have been demonstrated.[</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="6108" xml_f="6110" txt_i="2700" txt_f="2702">10</offsets></xref><xref ref-type="bibr" rid="ref11"><offsets xml_i="6151" xml_f="6153" txt_i="2702" txt_f="2704">11</offsets></xref><offsets xml_i="6160" xml_f="6377" txt_i="2704" txt_f="2921">] In chronic arthritis patients, intra-articular morphine injection provides analgesia, which is equivalent to dexamethasone. It is also possible that intra-articular morphine may have some anti-inflammatory actions.[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="6410" xml_f="6411" txt_i="2921" txt_f="2922">5</offsets></xref><offsets xml_i="6418" xml_f="6419" txt_i="2922" txt_f="2923">]</offsets></p><p><offsets xml_i="6426" xml_f="6677" txt_i="2924" txt_f="3175">There is no other study which compares long-term clinical effects of intra-articular morphine with dexamethasone in osteoarthritis of the knee in the literature. We aimed to compare intra-articular triamcinolone with morphine through a 12-week-period.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="6740" xml_f="6761" txt_i="3177" txt_f="3198">Materials and Methods</offsets></title><p><offsets xml_i="6772" xml_f="7107" txt_i="3199" txt_f="3534">After the approval, of local ethical committee, written informed consent was obtained from each included patient. A double blind, prospective, randomized, and controlled trial was conducted on different modes of intra-articular analgesia in patients suffering from osteoarthritis knee. The inclusion and exclusion criteria were as per </offsets><xref ref-type="table" rid="T1"><offsets xml_i="7139" xml_f="7146" txt_i="3534" txt_f="3541">Table 1</offsets></xref><offsets xml_i="7153" xml_f="7301" txt_i="3541" txt_f="3689">. Patients were randomized by the closed-envelope technique into three groups. Namely, Group M (morphine), Group T (steroid), and Group C (control).</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="7349" xml_f="7356" txt_i="3690" txt_f="3697">Table 1</offsets></label><caption><p><offsets xml_i="7376" xml_f="7408" txt_i="3697" txt_f="3729">Inclusion and exclusion criteria</offsets></p></caption><graphic xlink:href="JOACP-28-496-g001"></graphic></table-wrap><p><offsets xml_i="7488" xml_f="8685" txt_i="3730" txt_f="4927">In the supine position, the knee was flexed and a roll was placed under it. Under strict asepsis, a 1½-inch 25 G needle was placed between the patella and femoral condyle in the middle of the medial edge of patella. Local anesthetic was not used to the injection site. In Group M patients, morphine 5 mg (½ ml) with bupivacaine 20 mg (4 ml) and ½ ml saline (5 ml volume) was given intra-articularly. In Group T patients, triamcinolone acetonide 40 mg (1 ml) with bupivacaine 20 mg (4 ml) was given intra-articularly (5 ml volume). In Group C patients, 1 ml saline plus 20 mg bupivacaine (4 ml) was given intra-articularly (5 ml volume). Since the solutions were in different colors, sticker was used to cover injectors to hide to ensure blinding. Injections were administered by another blinded investigator. Patients were observed for 1 h after the injection. The knee was wrapped with compressive elastic bandage. Cold application was performed. After discharge, if there was persistent pain, patients were advised to take 1 g paracetamol orally three times daily. If there was persistent pain despite paracetamol, dexketoprofen trometamol 50 mg/daily orally was advised and its intake recorded.</offsets></p><p><offsets xml_i="8692" xml_f="8916" txt_i="4928" txt_f="5152">Pain severity was evaluated according to visual analog scale (VAS), by the same blinded physician, before injection, and in 2nd, 4th, 6th and 12th weeks after injection. The following parameters were recorded at every visit:</offsets></p><p><offsets xml_i="8923" xml_f="8924" txt_i="5153" txt_f="5154">
</offsets><list list-type="order"><list-item><p><offsets xml_i="8962" xml_f="9075" txt_i="5154" txt_f="5267">VAS scores at daily activities only for the injected knee (0 = no pain and 10 = worst and most severe pain ever).</offsets></p></list-item><list-item><p><offsets xml_i="9105" xml_f="9198" txt_i="5268" txt_f="5361">According to the Turkish version of WOMAC (Western Ontario and McMaster Universities) scale,[</offsets><xref ref-type="bibr" rid="ref15"><offsets xml_i="9232" xml_f="9234" txt_i="5361" txt_f="5363">15</offsets></xref><offsets xml_i="9241" xml_f="9272" txt_i="5363" txt_f="5394">] which contains 24 questions [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="9304" xml_f="9311" txt_i="5394" txt_f="5401">Table 2</offsets></xref><offsets xml_i="9318" xml_f="9510" txt_i="5401" txt_f="5593">], pain scores were evaluated according to WOMAC-P and WOMAC-S. WOMAC is a new multidimensional, self-administered health status instrument for patients with osteoarthritis of the hip or knee.</offsets></p></list-item><list-item><p><offsets xml_i="9540" xml_f="9683" txt_i="5594" txt_f="5737">Incidence of side effects, if any, such as itching, paresthesia, urinary retention, nausea-vomiting, dizziness-vertigo, and rash were recorded.</offsets></p></list-item></list><offsets xml_i="9706" xml_f="9707" txt_i="5738" txt_f="5739">
</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="9755" xml_f="9762" txt_i="5740" txt_f="5747">Table 2</offsets></label><caption><p><offsets xml_i="9782" xml_f="9807" txt_i="5747" txt_f="5772">WOMAC scale questionnaire</offsets></p></caption><graphic xlink:href="JOACP-28-496-g002"></graphic></table-wrap><p><offsets xml_i="9887" xml_f="10243" txt_i="5773" txt_f="6129">The SPSS 17.0 software program was used for statistical analysis. Efficacy of treatment was evaluated for each group using VAS, WOMAC-P, WOMAC-S, and WOMAC-F scores. Initial values and values in 2nd, 4th, 6th, and 12th weeks were analyzed with ANOVA one-way variance analysis. One-way ANOVA analysis was performed by post-hoc tests, Bonferroni correction. </offsets><italic><offsets xml_i="10251" xml_f="10252" txt_i="6129" txt_f="6130">P</offsets></italic><offsets xml_i="10261" xml_f="10482" txt_i="6130" txt_f="6348"> &lt; 0.016 was considered as significant. Then, efficacy of three groups was compared with each other using variance analysis of repeated measures. Supplementary analgesic consumption was evaluated with chi-square test. </offsets><italic><offsets xml_i="10490" xml_f="10491" txt_i="6348" txt_f="6349">P</offsets></italic><offsets xml_i="10500" xml_f="10553" txt_i="6349" txt_f="6399"> &lt; 0.05 was accepted as statistically significant.</offsets></p></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="10606" xml_f="10613" txt_i="6401" txt_f="6408">Results</offsets></title><p><offsets xml_i="10624" xml_f="10806" txt_i="6409" txt_f="6591">A total 82 patients were recruited, but 9 out of them were excluded later as they did not come for follow-up. There was no significant difference of demographic data between groups [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="10838" xml_f="10845" txt_i="6591" txt_f="6598">Table 3</offsets></xref><offsets xml_i="10852" xml_f="10854" txt_i="6598" txt_f="6600">].</offsets></p><table-wrap id="T3" position="float"><label><offsets xml_i="10902" xml_f="10909" txt_i="6601" txt_f="6608">Table 3</offsets></label><caption><p><offsets xml_i="10929" xml_f="10969" txt_i="6608" txt_f="6648">Demographic features of the three groups</offsets></p></caption><graphic xlink:href="JOACP-28-496-g003"></graphic></table-wrap><p><offsets xml_i="11049" xml_f="11127" txt_i="6649" txt_f="6727">The VAS baseline values in the three groups were not significantly different (</offsets><italic><offsets xml_i="11135" xml_f="11136" txt_i="6727" txt_f="6728">P</offsets></italic><offsets xml_i="11145" xml_f="11434" txt_i="6728" txt_f="7014"> &gt; 0.05). VAS scores of the control group had no significant change over 12 weeks of time. The morphine and steroid groups had significantly decreased VAS scores at every visit over 12 weeks. The morphine and steroid groups were compared with each other, and their scores were similar (</offsets><italic><offsets xml_i="11442" xml_f="11443" txt_i="7014" txt_f="7015">P</offsets></italic><offsets xml_i="11452" xml_f="11653" txt_i="7015" txt_f="7213"> &gt; 0.05). Variance analysis of repeated measurements revealed decreased VAS scores of both morphine and steroid groups than the control group and this decrease continued until the end of 12th week [</offsets><italic><offsets xml_i="11661" xml_f="11662" txt_i="7213" txt_f="7214">P</offsets></italic><offsets xml_i="11671" xml_f="11684" txt_i="7214" txt_f="7224"> &lt; 0.001, </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="11714" xml_f="11722" txt_i="7224" txt_f="7232">Figure 1</offsets></xref><offsets xml_i="11729" xml_f="11731" txt_i="7232" txt_f="7234">].</offsets></p><fig id="F1" position="float"><label><offsets xml_i="11772" xml_f="11780" txt_i="7235" txt_f="7243">Figure 1</offsets></label><caption><p><offsets xml_i="11800" xml_f="11838" txt_i="7243" txt_f="7281">VAS scores versus time in the groups. </offsets><sup><offsets xml_i="11843" xml_f="11844" txt_i="7281" txt_f="7282">*</offsets></sup><offsets xml_i="11850" xml_f="11890" txt_i="7282" txt_f="7322">Significance of Group M versus Group T, </offsets><italic><offsets xml_i="11898" xml_f="11899" txt_i="7322" txt_f="7323">P</offsets></italic><offsets xml_i="11908" xml_f="11920" txt_i="7323" txt_f="7332"> &gt; 0.05. </offsets><sup><offsets xml_i="11925" xml_f="11926" txt_i="7332" txt_f="7333">†</offsets></sup><offsets xml_i="11932" xml_f="11984" txt_i="7333" txt_f="7385">Significance of Group M and Group T versus Group C, </offsets><italic><offsets xml_i="11992" xml_f="11993" txt_i="7385" txt_f="7386">P</offsets></italic><offsets xml_i="12002" xml_f="12013" txt_i="7386" txt_f="7394"> &lt; 0.000</offsets></p></caption><graphic xlink:href="JOACP-28-496-g004"></graphic></fig><p><offsets xml_i="12086" xml_f="12269" txt_i="7395" txt_f="7578">WOMAC pain, stiffness and, function scores were compared using one-way ANOVA. VAS scores of morphine and steroid groups were significantly decreased in 2nd, 4th, 6th, and 12th weeks [</offsets><italic><offsets xml_i="12277" xml_f="12278" txt_i="7578" txt_f="7579">P</offsets></italic><offsets xml_i="12287" xml_f="12300" txt_i="7579" txt_f="7589"> &lt; 0.001, </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="12330" xml_f="12338" txt_i="7589" txt_f="7597">Figure 2</offsets></xref><offsets xml_i="12345" xml_f="12447" txt_i="7597" txt_f="7699">]. In three groups, there was a significant different compared in terms of the WOMAC baseline values (</offsets><italic><offsets xml_i="12455" xml_f="12456" txt_i="7699" txt_f="7700">P</offsets></italic><offsets xml_i="12465" xml_f="12661" txt_i="7700" txt_f="7893"> &gt; 0.05). Morphine and steroid groups were compared with each other using variance analysis of repeated measurements, and their WOMAC scores were also similar in 2nd, 4th, 6th, and 12th weeks [</offsets><italic><offsets xml_i="12669" xml_f="12670" txt_i="7893" txt_f="7894">P</offsets></italic><offsets xml_i="12679" xml_f="12691" txt_i="7894" txt_f="7903"> &gt; 0.05, </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="12721" xml_f="12729" txt_i="7903" txt_f="7911">Figure 2</offsets></xref><offsets xml_i="12736" xml_f="12738" txt_i="7911" txt_f="7913">].</offsets></p><fig id="F2" position="float"><label><offsets xml_i="12779" xml_f="12787" txt_i="7914" txt_f="7922">Figure 2</offsets></label><caption><p><offsets xml_i="12807" xml_f="12952" txt_i="7922" txt_f="8067">WOMAC scores versus time in the groups. (a) WOMAC - pain (0–20 point), (b) WOMAC - stiffness (0–8 point), and (c) WOMAC - function (0–68 point). </offsets><sup><offsets xml_i="12957" xml_f="12958" txt_i="8067" txt_f="8068">*</offsets></sup><offsets xml_i="12964" xml_f="13016" txt_i="8068" txt_f="8120">Significance of Group M and Group T versus Group C, </offsets><italic><offsets xml_i="13024" xml_f="13025" txt_i="8120" txt_f="8121">P</offsets></italic><offsets xml_i="13034" xml_f="13045" txt_i="8121" txt_f="8129"> &lt; 0.000</offsets></p></caption><graphic xlink:href="JOACP-28-496-g005"></graphic></fig><p><offsets xml_i="13118" xml_f="13418" txt_i="8130" txt_f="8430">Patients in the morphine and steroid groups needed significantly lesser NSAID supplementation than patients in the control group. However, all patients of the control group needed NSAID supplementation and paracetamol. The morphine group had significantly lower NSAID consumption than steroid group (</offsets><italic><offsets xml_i="13426" xml_f="13427" txt_i="8430" txt_f="8431">P</offsets></italic><offsets xml_i="13436" xml_f="13524" txt_i="8431" txt_f="8519"> = 0.036). No side effect was recorded for any patient during the conduct of this study.</offsets></p></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="13580" xml_f="13590" txt_i="8521" txt_f="8531">Discussion</offsets></title><p><offsets xml_i="13601" xml_f="13851" txt_i="8532" txt_f="8782">This study presents 12-week follow-up of 82 patients with osteoarthritis of the knee. We found that intra-articular morphine and triamcinolone had high analgesic efficacy. Intra-articular morphine had no side effects as observed in previous studies.[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="13884" xml_f="13885" txt_i="8782" txt_f="8783">5</offsets></xref><xref ref-type="bibr" rid="ref6"><offsets xml_i="13925" xml_f="13926" txt_i="8783" txt_f="8784">6</offsets></xref><offsets xml_i="13933" xml_f="14140" txt_i="8784" txt_f="8991">] No patient in this study had any adverse effects during 12 weeks. We used two different measurement methods (VAS and WOMAC) to assess pain relief and functional improvement of the knee joint in this study.</offsets></p><p><offsets xml_i="14147" xml_f="14327" txt_i="8992" txt_f="9172">The exact mechanism of analgesic and anti-inflammatory effect of intra-articular morphine is not known yet. Probably, opioid receptors of peripheral nerve terminals are activated.[</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="14360" xml_f="14361" txt_i="9172" txt_f="9173">9</offsets></xref><offsets xml_i="14368" xml_f="14369" txt_i="9173" txt_f="9174">–</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="14403" xml_f="14405" txt_i="9174" txt_f="9176">11</offsets></xref><offsets xml_i="14412" xml_f="14664" txt_i="9176" txt_f="9428">] Opioid receptors are synthesized at dorsal root ganglions and transferred to nerve terminals via axonal route. When these receptors are stimulated, both endogenous and exogenous opioid peptides are activated simultaneously inside inflammatory cells.[</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="14698" xml_f="14700" txt_i="9428" txt_f="9430">10</offsets></xref><offsets xml_i="14707" xml_f="15040" txt_i="9430" txt_f="9763">] Local opioid-dependent analgesic actions are more pronounced in inflamed tissues than noninflamed tissues. This may be because of increased coupling with G-proteins, and/or may be associated with the increased number of exposed opioid receptors (which are exposed after degradation of perineural barriers and passage of agonists).[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="15073" xml_f="15074" txt_i="9763" txt_f="9764">8</offsets></xref><xref ref-type="bibr" rid="ref16"><offsets xml_i="15115" xml_f="15117" txt_i="9764" txt_f="9766">16</offsets></xref><offsets xml_i="15124" xml_f="15125" txt_i="9766" txt_f="9767">]</offsets></p><p><offsets xml_i="15132" xml_f="15298" txt_i="9768" txt_f="9934">Intra-articular steroid and morphine were compared in chronic arthritis patients for relief of pain severity and both were found to provide pain relief for 2–6 days.[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="15331" xml_f="15332" txt_i="9934" txt_f="9935">5</offsets></xref><offsets xml_i="15339" xml_f="15448" txt_i="9935" txt_f="10044">] We too found that intra-articular morphine provided long-term pain relief in patients with osteoarthritis.[</offsets><xref ref-type="bibr" rid="ref6"><offsets xml_i="15481" xml_f="15482" txt_i="10044" txt_f="10045">6</offsets></xref><xref ref-type="bibr" rid="ref7"><offsets xml_i="15522" xml_f="15523" txt_i="10045" txt_f="10046">7</offsets></xref><offsets xml_i="15530" xml_f="15735" txt_i="10046" txt_f="10251">] Morphine may inhibit the nociceptive sensitization or excitation of peripheral sensory neurons and development of long-term excitatory effects in spinal cord (wind-up) proinflammatory reflex mechanisms.[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="15769" xml_f="15771" txt_i="10251" txt_f="10253">11</offsets></xref><offsets xml_i="15778" xml_f="15779" txt_i="10253" txt_f="10254">]</offsets></p><p><offsets xml_i="15786" xml_f="16226" txt_i="10255" txt_f="10695">Low blood flow of the knee joint together with low clearance of synovial fluid may contribute to long-lasting analgesic effect. The long-term analgesic effect may also be due to low lipid solubility of morphine with low absorption rate. Morphine metabolites too have an analgesic effect. Furthermore, morphine has cellular pro-proliferative effects, which may be associated with cartilage regeneration and regulation of chondrocyte growth.[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="16259" xml_f="16260" txt_i="10695" txt_f="10696">8</offsets></xref><offsets xml_i="16267" xml_f="16268" txt_i="10696" txt_f="10697">]</offsets></p><p><offsets xml_i="16275" xml_f="16703" txt_i="10698" txt_f="11126">Instead of systemic absorption, morphine was shown to stay inside the knee joint after intra-articular injection. In a study, comparing same doses of intra-articular with intravenous morphine, significantly different plasma levels were found. Intra-articular morphine has significantly lower systemic side effects, such as nausea-vomiting, dizziness-vertigo, constipation, dependency-abuse, compared to systemic administration.[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="16736" xml_f="16737" txt_i="11126" txt_f="11127">5</offsets></xref><offsets xml_i="16744" xml_f="16745" txt_i="11127" txt_f="11128">]</offsets></p><p><offsets xml_i="16752" xml_f="16980" txt_i="11129" txt_f="11357">Studies have shown that demographic features have a role in effectiveness of morphine, in treatment of both acute and chronic pain. Clinical presentation and side effects of opioids are affected by demographic features as well.[</offsets><xref ref-type="bibr" rid="ref17"><offsets xml_i="17014" xml_f="17016" txt_i="11357" txt_f="11359">17</offsets></xref><offsets xml_i="17023" xml_f="17024" txt_i="11359" txt_f="11360">–</offsets><xref ref-type="bibr" rid="ref19"><offsets xml_i="17058" xml_f="17060" txt_i="11360" txt_f="11362">19</offsets></xref><offsets xml_i="17067" xml_f="17442" txt_i="11362" txt_f="11737">] Patients in our study were of low socioeconomically and educational status. However, the compliance of patients was good and increased because their pain stopped a few minutes after intra-articular injections. All injections are performed by the same experienced doctor at the first attempt. Nine patients were excluded from as they did not come for follow-up examinations.</offsets></p><p><offsets xml_i="17449" xml_f="17641" txt_i="11738" txt_f="11930">There is a minimal risk of injury to joint with single-shot corticosteroid injection. On the other hand, long-term triamcinolone injection may lead to harmful consequences to joint cartilage.[</offsets><xref ref-type="bibr" rid="ref20"><offsets xml_i="17675" xml_f="17677" txt_i="11930" txt_f="11932">20</offsets></xref><offsets xml_i="17684" xml_f="17799" txt_i="11932" txt_f="12047">] Long-term and repeated intra-articular steroid injections may lead to serious side effects of systemic steroids.[</offsets><xref ref-type="bibr" rid="ref21"><offsets xml_i="17833" xml_f="17835" txt_i="12047" txt_f="12049">21</offsets></xref><offsets xml_i="17842" xml_f="17843" txt_i="12049" txt_f="12050">–</offsets><xref ref-type="bibr" rid="ref23"><offsets xml_i="17877" xml_f="17879" txt_i="12050" txt_f="12052">23</offsets></xref><offsets xml_i="17886" xml_f="17965" txt_i="12052" txt_f="12131">] The most feared consequence is steroid-induced arthropathy and joint sepsis.[</offsets><xref ref-type="bibr" rid="ref2"><offsets xml_i="17998" xml_f="17999" txt_i="12131" txt_f="12132">2</offsets></xref><xref ref-type="bibr" rid="ref24"><offsets xml_i="18040" xml_f="18042" txt_i="12132" txt_f="12134">24</offsets></xref><xref ref-type="bibr" rid="ref25"><offsets xml_i="18083" xml_f="18085" txt_i="12134" txt_f="12136">25</offsets></xref><offsets xml_i="18092" xml_f="18173" txt_i="12136" txt_f="12217">] Every injection causes some degree of anxiety to the physicians performing it.[</offsets><xref ref-type="bibr" rid="ref26"><offsets xml_i="18207" xml_f="18209" txt_i="12217" txt_f="12219">26</offsets></xref><offsets xml_i="18216" xml_f="18384" txt_i="12219" txt_f="12387">] However, one study suggests that there are no adverse effects, to anatomical structures of the knee joint, of steroid injections at 3 month intervals within 2 years.[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="18417" xml_f="18418" txt_i="12387" txt_f="12388">3</offsets></xref><offsets xml_i="18425" xml_f="18636" txt_i="12388" txt_f="12599">] Lipid necrosis, dermal atrophy, depigmentation, and subcutaneous tissue atrophy are minor local complications seen near the injection site. Malposition of the needle may cause these minor local complications.[</offsets><xref ref-type="bibr" rid="ref21"><offsets xml_i="18670" xml_f="18672" txt_i="12599" txt_f="12601">21</offsets></xref><offsets xml_i="18679" xml_f="18784" txt_i="12601" txt_f="12706">] Easy-one-shot injection is performed with 1½-inch 25 G needle directly without any risk of malposition.</offsets></p><p><offsets xml_i="18791" xml_f="19232" txt_i="12707" txt_f="13148">Intra-articular analgesic drug administration helps reduce consumption of oral analgesic/anti-inflammatory drugs. Our control group had insufficient level of analgesia with paracetamol, and their VAS/WOMAC scores were high; therefore, we had to give dexketoprofen trometamol to these patients in addition to paracetamol. The morphine and steroid groups had significantly lower consumption of other analgesics and their pain scores were low.[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="19265" xml_f="19266" txt_i="13148" txt_f="13149">5</offsets></xref><offsets xml_i="19273" xml_f="19576" txt_i="13149" txt_f="13452">] All of the included patients refused arthroscopic debridement and/or knee prosthesis operations. They had to use NSAID for longer terms and were prone to their gastrointestinal side effects. NSAID complication costs are at least three times higher than the cost of intra-articular steroid injections.[</offsets><xref ref-type="bibr" rid="ref24"><offsets xml_i="19610" xml_f="19612" txt_i="13452" txt_f="13454">24</offsets></xref><offsets xml_i="19619" xml_f="19620" txt_i="13454" txt_f="13455">]</offsets></p><p><offsets xml_i="19627" xml_f="19918" txt_i="13456" txt_f="13747">In conclusion, intra-articular morphine has comparable efficacy with intra-articular triamcinolone injection in pain relief. Nevertheless, further studies are needed for evaluation of dosage and effectiveness in different and /or larger patient populations in order to confirm these results.</offsets></p></sec></body><back><ack><p>Authors would like to thank Dr. Aydın ECE for him valuable contribution related to the data collection, the statistical analysis and for editing the manuscript. Funding for this study was provided by Boztepe State Hospital, Ordu, Republic of Turkey.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravaud</surname><given-names>P</given-names></name><name><surname>Moulinier</surname><given-names>L</given-names></name><name><surname>Giraudeau</surname><given-names>B</given-names></name><name><surname>Ayral</surname><given-names>X</given-names></name><name><surname>Guerin</surname><given-names>C</given-names></name><name><surname>Noel</surname><given-names>E</given-names></name></person-group><article-title>Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: Results of a multicenter, randomized, controlled trial</article-title><source>Arthritis Rheum</source><year>1999</year><volume>42</volume><fpage>475</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">10088770</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neustadt</surname><given-names>DH</given-names></name></person-group><article-title>Intra-articular injections for osteoarthritis of the knee</article-title><source>Cleve Clin J Med</source><year>2006</year><volume>73</volume><fpage>897</fpage><lpage>8</lpage><series>901-4, 906-11</series><pub-id pub-id-type="pmid">17044315</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raynauld</surname><given-names>JP</given-names></name><name><surname>Buckland-Wright</surname><given-names>C</given-names></name><name><surname>Ward</surname><given-names>R</given-names></name><name><surname>Choquette</surname><given-names>D</given-names></name><name><surname>Haraoui</surname><given-names>B</given-names></name><name><surname>Martel-Pelletier</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Safety and efficacy of longterm intraarticular steroid injections in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial</article-title><source>Arthritis Rheum</source><year>2003</year><volume>48</volume><fpage>370</fpage><lpage>7</lpage><comment>Erratum in: Arthritis Rheum. 2003;48:3300</comment><pub-id pub-id-type="pmid">12571845</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uthman</surname><given-names>I</given-names></name><name><surname>Raynauld</surname><given-names>JP</given-names></name><name><surname>Haraoui</surname><given-names>B</given-names></name></person-group><article-title>Intra-articular therapy in osteoarthritis</article-title><source>Postgrad Med J</source><year>2003</year><volume>79</volume><fpage>449</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">12954956</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>A</given-names></name><name><surname>Yassouridis</surname><given-names>A</given-names></name><name><surname>Szopko</surname><given-names>C</given-names></name><name><surname>Helmke</surname><given-names>K</given-names></name><name><surname>Stein</surname><given-names>C</given-names></name></person-group><article-title>Intraarticular morphine versus dexamethasone in chronic arthritis</article-title><source>Pain</source><year>1999</year><volume>83</volume><fpage>525</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">10568861</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Likar</surname><given-names>R</given-names></name><name><surname>Schäfer</surname><given-names>M</given-names></name><name><surname>Paulak</surname><given-names>F</given-names></name><name><surname>Sittl</surname><given-names>R</given-names></name><name><surname>Pipam</surname><given-names>W</given-names></name><name><surname>Schalk</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Intraarticular morphine analgesia in chronic pain patients with osteoarthritis</article-title><source>Anesth Analg</source><year>1997</year><volume>84</volume><fpage>1313</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9174312</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Bodin</surname><given-names>L</given-names></name><name><surname>Holmström</surname><given-names>B</given-names></name><name><surname>Berggren</surname><given-names>L</given-names></name></person-group><article-title>A systematic review of the peripheral analgesic effects of intraarticular morphine</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><fpage>761</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11524353</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elvenes</surname><given-names>J</given-names></name><name><surname>Andjelkov</surname><given-names>N</given-names></name><name><surname>Figenschau</surname><given-names>Y</given-names></name><name><surname>Seternes</surname><given-names>T</given-names></name><name><surname>Bjørkøy</surname><given-names>G</given-names></name><name><surname>Johansen</surname><given-names>O</given-names></name></person-group><article-title>Expression of functional mu-opioid receptors in human osteoarthritic cartilage and chondrocytes</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><volume>311</volume><fpage>202</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14575714</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mousa</surname><given-names>SA</given-names></name><name><surname>Straub</surname><given-names>RH</given-names></name><name><surname>Schäfer</surname><given-names>M</given-names></name><name><surname>Stein</surname><given-names>C</given-names></name></person-group><article-title>Beta-endorphin, met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis</article-title><source>Ann Rheum Dis</source><year>2007</year><volume>66</volume><fpage>871</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17324971</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>C</given-names></name></person-group><article-title>The control of pain in peripheral tissue by opioids</article-title><source>N Engl J Med</source><year>1995</year><volume>332</volume><fpage>1685</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">7760870</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>C</given-names></name><name><surname>Clark</surname><given-names>JD</given-names></name><name><surname>Oh</surname><given-names>U</given-names></name><name><surname>Vasko</surname><given-names>MR</given-names></name><name><surname>Wilcox</surname><given-names>GL</given-names></name><name><surname>Overland</surname><given-names>AC</given-names></name><etal></etal></person-group><article-title>Peripheral mechanisms of pain and analgesia</article-title><source>Brain Res Rev</source><year>2009</year><volume>60</volume><fpage>90</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">19150465</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>R</given-names></name><name><surname>Asch</surname><given-names>E</given-names></name><name><surname>Bloch</surname><given-names>D</given-names></name><name><surname>Bole</surname><given-names>G</given-names></name><name><surname>Borenstein</surname><given-names>D</given-names></name><name><surname>Brandt</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association</article-title><source>Arthritis Rheum</source><year>1986</year><volume>29</volume><fpage>1039</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">3741515</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellgren</surname><given-names>JH</given-names></name><name><surname>Lawrence</surname><given-names>JS</given-names></name></person-group><article-title>Radiological assessment of osteo-arthrosis</article-title><source>Ann Rheum Dis</source><year>1957</year><volume>6</volume><fpage>494</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">13498604</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>R</given-names></name><name><surname>Brandt</surname><given-names>T</given-names></name><name><surname>Hochberg</surname><given-names>M</given-names></name><name><surname>Moskovitz</surname><given-names>R</given-names></name></person-group><article-title>Design and conduct of clinical trials of patients with osteoarthritis.Recommendations from a task force of the osteoarthritis research society</article-title><source>Osteoarthritis Cartilage</source><year>1996</year><volume>4</volume><fpage>217</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">11048620</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tüzün</surname><given-names>EH</given-names></name><name><surname>Eker</surname><given-names>L</given-names></name><name><surname>Aytar</surname><given-names>A</given-names></name><name><surname>Daşkapan</surname><given-names>A</given-names></name><name><surname>Bayramoğlu</surname><given-names>M</given-names></name></person-group><article-title>Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index</article-title><source>Osteoarthritis Cartilage</source><year>2005</year><volume>13</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">15639634</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegeder</surname><given-names>I</given-names></name><name><surname>Meier</surname><given-names>S</given-names></name><name><surname>Burian</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Geisslinger</surname><given-names>G</given-names></name><name><surname>Lötsch</surname><given-names>J</given-names></name></person-group><article-title>Peripheral opioid analgesia in experimental human pain models</article-title><source>Brain</source><year>2003</year><volume>126</volume><fpage>1092</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">12690049</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolesnikov</surname><given-names>Y</given-names></name><name><surname>Gabovits</surname><given-names>B</given-names></name><name><surname>Levin</surname><given-names>A</given-names></name><name><surname>Voiko</surname><given-names>E</given-names></name><name><surname>Veske</surname><given-names>A</given-names></name></person-group><article-title>Combined catechol-o-methyltransferase and {micro}-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects</article-title><source>Anesth Analg</source><year>2011</year><volume>112</volume><fpage>448</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">21127283</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishizawa</surname><given-names>D</given-names></name><name><surname>Hayashida</surname><given-names>M</given-names></name><name><surname>Nagashima</surname><given-names>M</given-names></name><name><surname>Koga</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name></person-group><article-title>Genetic polymorphisms and human sensitivity to opioid analgesics</article-title><source>Methods Mol Biol</source><year>2010</year><volume>617</volume><fpage>395</fpage><lpage>420</lpage><pub-id pub-id-type="pmid">20336437</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>J</given-names></name><name><surname>Hamet</surname><given-names>P</given-names></name></person-group><article-title>Genetics of pain, opioids, and opioid responsiveness</article-title><source>Metabolism</source><year>2010</year><volume>59</volume><issue>Suppl 1</issue><fpage>S5</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20837195</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Céleste</surname><given-names>C</given-names></name><name><surname>Ionescu</surname><given-names>M</given-names></name><name><surname>Robin Poole</surname><given-names>A</given-names></name><name><surname>Laverty</surname><given-names>S</given-names></name></person-group><article-title>Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid</article-title><source>J Orthop Res</source><year>2005</year><volume>23</volume><fpage>602</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">15885481</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Ho</surname><given-names>ST</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Tang</surname><given-names>JJ</given-names></name><name><surname>Liaw</surname><given-names>WJ</given-names></name></person-group><article-title>Intraarticular triamcinolone acetonide for pain control after arthroscopic knee surgery</article-title><source>Anesth Analg</source><year>1998</year><volume>87</volume><fpage>1113</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9806691</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grillet</surname><given-names>B</given-names></name><name><surname>Dequeker</surname><given-names>J</given-names></name></person-group><article-title>Intra-articular steroid injection.A risk-benefit assessment</article-title><source>Drug Saf</source><year>1990</year><volume>5</volume><fpage>205</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">2190596</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosal</surname><given-names>HS</given-names></name><name><surname>Jackson</surname><given-names>AM</given-names></name><name><surname>Bickerstaff</surname><given-names>DR</given-names></name></person-group><article-title>Intra-articular steroids after arthroscopy for osteoarthritis of the knee</article-title><source>J Bone Joint Surg Br</source><year>1999</year><volume>81</volume><fpage>952</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10615964</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>S</given-names></name><name><surname>Longworth</surname><given-names>S</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Saunders</surname><given-names>S</given-names></name><name><surname>Longworth</surname><given-names>S</given-names></name></person-group><article-title>İnjection techniques in orthopaedics and sports medicine</article-title><source>Section 1: Guidelines and procedures</source><year>2006</year><edition>Third ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Elservier Churchill Livingstone</publisher-name><fpage>3</fpage><lpage>15</lpage></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seror</surname><given-names>P</given-names></name><name><surname>Pluvinage</surname><given-names>P</given-names></name><name><surname>d’Andre</surname><given-names>FL</given-names></name><name><surname>Benamou</surname><given-names>P</given-names></name><name><surname>Attuil</surname><given-names>G</given-names></name></person-group><article-title>Frequency of sepsis after local corticosteroid injection (an inquiry on 1160000 injections in rheumatological private practice in France)</article-title><source>Rheumatology (Oxford)</source><year>1999</year><volume>38</volume><fpage>1272</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10587558</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>G</given-names></name></person-group><article-title>Steroid arthropathy: Myth or reality?</article-title><source>J Orth Med</source><year>1995</year><volume>17</volume><fpage>51</fpage><lpage>5</lpage></element-citation></ref></ref-list></back></article>